Memorial Sloan Kettering Cancer Center; Weill Cornell Medical College
Chief, Endocrinology Service. Member, Human Oncology and Pathogenesis Program. Memorial Sloan Kettering Cancer Center. Professor of Medicine.

Senior Research Associate
Institut de Recherche Interdisciplinaire en Biologie Humaine et moléculaire
Université Libre de Bruxelles, Belgium.

“Imperial College London Society for Endocrinology”

“Graham Williams became Professor of Endocrinology at Imperial College London in 2005. He is Head of the Molecular Endocrinology Laboratory in the Department of Medicine at Hammersmith Campus. His research focuses on the (i) genetic origins of bone and cartilage disease and (ii) molecular mechanisms of thyroid hormone action during skeletal development and in adult bone maintenance and tissue repair. This research is internationally recognised and the laboratory is generously funded by a Wellcome Trust Strategic Award, MRC Research Grant, European Commission Horizon 2020 Award and Wellcome Trust Investigator Award.

Professor Williams is the current President of the Society for Endocrinology (2016-2019), having previously served as Treasurer and a Member of Council (2010-2015).”

“Erasmus MC Academic Center for Thyroid Diseases Erasmus MC, Rotterdam, The Netherlands”

Robin P. Peeters, MD PhD. Professor of Internal Medicine. Head of Erasmus MC Academic Center for Thyroid Diseases. Erasmus MC, Rotterdam, The Netherlands.

University of California at San Francisco-UCSF

Julie Ann Sosa, MD MA FACS. Leon Goldman, MD Distinguished Professor of Surgery and Chair, Department of Surgery. Professor, Department of Medicine. University of California at San Francisco-UCSF.

University of Texas MD Anderson Cancer Center in Houston, Texas

Maria E. Cabanillas, M.D. is an Oncologic Endocrinologist at the University of Texas MD Anderson Cancer Center in Houston, Texas. She is a tenured Associate Professor and the Faculty Director of Clinical Research in the department of Endocrine Neoplasia at MD Anderson. Dr. Cabanillas serves as the principal investigator on several clinical trials for the treatment of advanced and metastatic thyroid cancer and is an IRB vice-chair. She has been a member of the International Thyroid Oncology Group (ITOG) since 2012 and is currently on the Board of Directives.